Lauren Silvernail — Chief Financial Officer, Chief Business Officer and Secretary at Revance Therapeutics

Mrs. Lauren P. Silvernail has been the Chief Financial Officer at Revance Therapeutics, Inc. since March 25, 2013 and serves as its Principal Financial & Accounting Officer and Secretary. Mrs. Silvernail has been the Chief Business Officer of Revance Therapeutics, Inc. since December 14, 2015. Mrs. Silvernail served as Executive Vice President of Corporate Development since March 25,2013 until December 2015. She served as the Chief Financial Officer and Vice President of Corporate Development at ISTA Pharmaceuticals Inc. since March 2003. From 1995 to March 2003, Mrs. Silvernail served in various operating and corporate development positions for Allergan, Inc., including Vice President of Business Development. From 1989 to 1994, she served as a General Partner at Glenwood Ventures and served as a Director and Operating Manager for several portfolio companies. She served as the Chief Accounting Officer of ISTA Pharmaceuticals Inc. since March 2003. She has been Director at Nicox SA since May 2017. Mrs. Silvernail received an M.B.A. from the University of California, Los Angeles.